HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trends in pulmonary function and prevalence of asthma in hexamethylene diisocyanate workers during a 19-year period.

AbstractOBJECTIVE:
To identify if 1,6-hexamethylene diisocyanate (HDI) workers demonstrated an increased prevalence of occupational asthma or accelerated decline in pulmonary function.
METHODS:
Employees from two plants manufacturing or producing 1,6-HDI monomer and/or HDI polyisocyanates were matched to a control population by age, gender, race, and smoking status. A random coefficient regression analysis compared the decline in pulmonary function test values over time. Retrospective medical review was used to identify potential cases of occupationally induced asthma.
RESULTS:
No significantly accelerated annual decline in force expiratory volume after 1 second in the HDI exposure group compared to the matched control group was observed. No cases of adult onset asthma, beyond those present at time of hire, and no cases of occupational asthma were identified.
CONCLUSIONS:
This study provides support for the current American Conference of Governmental Industrial Hygienists threshold limit value time-weighted average of 5 ppb.
AuthorsLaura D Cassidy, Donald M Molenaar, James A Hathaway, Timothy M Feeley, Barbara J Cummings, Pippa Simpson, Shun-Hwa Li
JournalJournal of occupational and environmental medicine (J Occup Environ Med) Vol. 52 Issue 10 Pg. 988-94 (Oct 2010) ISSN: 1536-5948 [Electronic] United States
PMID20881627 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Air Pollutants, Occupational
  • Cyanates
  • Isocyanates
  • 1,6-hexamethylene diisocyanate
Topics
  • Adult
  • Air Pollutants, Occupational (toxicity)
  • Asthma (chemically induced, epidemiology)
  • Cohort Studies
  • Cyanates (toxicity)
  • Female
  • Humans
  • Isocyanates
  • Male
  • Medical Audit
  • Middle Aged
  • Occupational Exposure (adverse effects)
  • Respiration
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: